| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 5 | |
| #2 | Australia | 4 | |
| #3 | Canada | 4 | |
| #4 | WIPO (World Intellectual Property Organization) | 4 | |
| #5 | United States | 2 | |
| #6 | India | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Unspecified technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Popescu Mircea C | 19 |
| #2 | Batenjany Michael M | 14 |
| #3 | Boni Lawrence | 9 |
| #4 | Robb Richard J | 8 |
| #5 | Gevantmakher Stella | 6 |
| #6 | Boni Lawrence T | 6 |
| #7 | Kwak Larry | 5 |
| #8 | Boni Larry | 5 |
| #9 | Ochoa Augusto C | 5 |
| #10 | Neville Mary E | 4 |
| Publication | Filing date | Title |
|---|---|---|
| EP1045688A1 | Lipomatrix preparation | |
| EP1045698A1 | Patient-specific white blood cell malignancy vaccine from membrane-proteoliposomes | |
| EP1523977A1 | Multilamellar coalescence vesicles (MLCV) containing biologically active compounds | |
| EP1019026A2 | Multilamellar coalescence vesicles (mlcv) containing biologically active compounds | |
| AU2273497A | Vaccine for b-cell malignancies |